This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steppan, C. M.
Right arrow Articles by Lazar, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steppan, C. M.
Right arrow Articles by Lazar, M. A.

 Previous Article

Molecular and Cellular Biology, February 2005, p. 1569-1575, Vol. 25, No. 4
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.4.1569-1575.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Activation of SOCS-3 by Resistin{dagger}

Claire M. Steppan,1* Juan Wang,1 Eileen L. Whiteman,1,2 Morris J. Birnbaum,1,2 and Mitchell A. Lazar1*

Division of Endocrinology, Diabetes, and Metabolism, Penn Diabetes Center and The Cox Institute,1 Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania2

Received 14 May 2004/ Returned for modification 29 June 2004/ Accepted 10 November 2004

Resistin is an adipocyte hormone that modulates glucose homeostasis. Here we show that in 3T3-L1 adipocytes, resistin attenuates multiple effects of insulin, including insulin receptor (IR) phosphorylation, IR substrate 1 (IRS-1) phosphorylation, phosphatidylinositol-3-kinase (PI3K) activation, phosphatidylinositol triphosphate production, and activation of protein kinase B/Akt. Remarkably, resistin treatment markedly induces the gene expression of suppressor of cytokine signaling 3 (SOCS-3), a known inhibitor of insulin signaling. The 50% effective dose for resistin induction of SOCS-3 is ~20 ng/ml, close to levels of resistin in serum. Association of SOCS-3 protein with the IR is also increased by resistin. Inhibition of SOCS function prevented resistin from antagonizing insulin action in adipocytes. SOCS-3 induction is the first cellular effect of resistin that is independent of insulin and is a likely mediator of resistin's inhibitory effect on insulin signaling in adipocytes.


* Corresponding author. Present address for Claire M. Steppan: Pfizer Inc., PRGD, MS220-3145, Eastern Point Rd., Groton, CT 06340. Phone: (860) 686-2717. Fax: (860) 715-4610. E-mail: claire.m.steppan{at}pfizer.com. Mailing address for Mitchell A. Lazar: University of Pennsylvania School of Medicine, CRB 611, 415 Curie Blvd., Philadelphia, PA 19104. Phone: (215) 898-0198. Fax: (215) 898-5408. E-mail: lazar{at}mail.med.upenn.edu.

* Corresponding author. Present address for Claire M. Steppan: Pfizer Inc., PRGD, MS220-3145, Eastern Point Rd., Groton, CT 06340. Phone: (860) 686-2717. Fax: (860) 715-4610. E-mail: claire.m.steppan{at}pfizer.com. Mailing address for Mitchell A. Lazar: University of Pennsylvania School of Medicine, CRB 611, 415 Curie Blvd., Philadelphia, PA 19104. Phone: (215) 898-0198. Fax: (215) 898-5408. E-mail: lazar{at}mail.med.upenn.edu.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.


Molecular and Cellular Biology, February 2005, p. 1569-1575, Vol. 25, No. 4
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.4.1569-1575.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Steinberg, G. R., Kemp, B. E. (2009). AMPK in Health and Disease. Physiol. Rev. 89: 1025-1078 [Abstract] [Full Text]  
  • Jorgensen, S. B., Honeyman, J., Oakhill, J. S., Fazakerley, D., Stockli, J., Kemp, B. E., Steinberg, G. R. (2009). Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 297: E57-E66 [Abstract] [Full Text]  
  • Hausman, G. J., Dodson, M. V., Ajuwon, K., Azain, M., Barnes, K. M., Guan, L. L., Jiang, Z., Poulos, S. P., Sainz, R. D., Smith, S., Spurlock, M., Novakofski, J., Fernyhough, M. E., Bergen, W. G. (2009). BOARD-INVITED REVIEW: The biology and regulation of preadipocytes and adipocytes in meat animals. J ANIM SCI 87: 1218-1246 [Abstract] [Full Text]  
  • Cohen, G., Ilic, D., Raupachova, J., Horl, W. H. (2008). Resistin Inhibits Essential Functions of Polymorphonuclear Leukocytes. J. Immunol. 181: 3761-3768 [Abstract] [Full Text]  
  • Vazquez, M. J., Gonzalez, C. R., Varela, L., Lage, R., Tovar, S., Sangiao-Alvarellos, S., Williams, L. M., Vidal-Puig, A., Nogueiras, R., Lopez, M., Dieguez, C. (2008). Central Resistin Regulates Hypothalamic and Peripheral Lipid Metabolism in a Nutritional-Dependent Fashion. Endocrinology 149: 4534-4543 [Abstract] [Full Text]  
  • Huang, X., Moore, D. J., Ketchum, R. J., Nunemaker, C. S., Kovatchev, B., McCall, A. L., Brayman, K. L. (2008). Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation. Endocr. Rev. 29: 603-630 [Abstract] [Full Text]  
  • Lee, M.-J., Lin, H., Liu, C.-W., Wu, M.-H., Liao, W.-J., Chang, H.-H., Ku, H.-C., Chien, Y.-S., Ding, W.-H., Kao, Y.-H. (2008). Octylphenol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways. Am. J. Physiol. Cell Physiol. 294: C1542-C1551 [Abstract] [Full Text]  
  • Kim, S.-J., Nian, C., McIntosh, C. H. S. (2007). Resistin Is a Key Mediator of Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Lipoprotein Lipase (LPL) Activity in Adipocytes. J. Biol. Chem. 282: 34139-34147 [Abstract] [Full Text]  
  • Singhal, N. S., Lazar, M. A., Ahima, R. S. (2007). Central Resistin Induces Hepatic Insulin Resistance via Neuropeptide Y. J. Neurosci. 27: 12924-12932 [Abstract] [Full Text]  
  • Qatanani, M., Lazar, M. A. (2007). Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21: 1443-1455 [Abstract] [Full Text]  
  • Harmancey, R., Senard, J.-M., Rouet, P., Pathak, A., Smih, F. (2007). Adrenomedullin Inhibits Adipogenesis Under Transcriptional Control of Insulin. Diabetes 56: 553-563 [Abstract] [Full Text]  
  • Torisu, T., Sato, N., Yoshiga, D., Kobayashi, T., Yoshioka, T., Mori, H., Iida, M., Yoshimura, A. (2007). The dual function of hepatic SOCS3 in insulin resistance in vivo.. GENES CELLS 12: 143-154 [Abstract] [Full Text]  
  • Kusminski, C. M., da Silva, N. F., Creely, S. J., Fisher, F. M., Harte, A. L., Baker, A. R., Kumar, S., McTernan, P. G. (2007). The in Vitro Effects of Resistin on the Innate Immune Signaling Pathway in Isolated Human Subcutaneous Adipocytes. J. Clin. Endocrinol. Metab. 92: 270-276 [Abstract] [Full Text]  
  • Qi, Y., Nie, Z., Lee, Y.-S., Singhal, N. S., Scherer, P. E., Lazar, M. A., Ahima, R. S. (2006). Loss of Resistin Improves Glucose Homeostasis in Leptin Deficiency. Diabetes 55: 3083-3090 [Abstract] [Full Text]  
  • Sands, W. A., Woolson, H. D., Milne, G. R., Rutherford, C., Palmer, T. M. (2006). Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells.. Mol. Cell. Biol. 26: 6333-6346 [Abstract] [Full Text]  
  • Chen, Y.-H., Lee, M.-J., Chang, H.-H., Hung, P.-F., Kao, Y.-H. (2006). 17{beta}-Estradiol Stimulates Resistin Gene Expression in 3T3-L1 Adipocytes via the Estrogen Receptor, Extracellularly Regulated Kinase, and CCAAT/Enhancer Binding Protein-{alpha} Pathways. Endocrinology 147: 4496-4504 [Abstract] [Full Text]  
  • Nair, M. G., Guild, K. J., Artis, D. (2006). Novel Effector Molecules in Type 2 Inflammation: Lessons Drawn from Helminth Infection and Allergy. J. Immunol. 177: 1393-1399 [Full Text]  
  • Spangenburg, E. E., Brown, D. A., Johnson, M. S., Moore, R. L. (2006). Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J. Physiol. 572: 839-848 [Abstract] [Full Text]  
  • Liu, H.-S., Chen, Y.-H., Hung, P.-F., Kao, Y.-H. (2006). Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway. Am. J. Physiol. Endocrinol. Metab. 290: E273-E281 [Abstract] [Full Text]  
  • Graveleau, C., Zaha, V. G., Mohajer, A., Banerjee, R. R., Dudley-Rucker, N., Steppan, C. M., Rajala, M. W., Scherer, P. E., Ahima, R. S., Lazar, M. A., Abel, E. D. (2005). Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological Action. J. Biol. Chem. 280: 31679-31685 [Abstract] [Full Text]  
  • Barb, D., Wadhwa, S. G., Kratzsch, J., Gavrila, A., Chan, J. L., Williams, C. J., Karchmer, A. W., Mantzoros, C. S. (2005). Circulating Resistin Levels Are Not Associated with Fat Redistribution, Insulin Resistance, or Metabolic Profile in Patients with the Highly Active Antiretroviral Therapy-Induced Metabolic Syndrome. J. Clin. Endocrinol. Metab. 90: 5324-5328 [Abstract] [Full Text]